Renal Effects of Nonsteroidal Antiinflammatory Drugs

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 21, Issue 10, 1999, Pages 910-919

  Forrester, S Dru ^a,b   Troy, Gregory C ^a,b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b AMER COLL OF VET INT MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000814552     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Holtsinger RH, Parker RB, Beale BS, et al: The therapeutic efficacy of carprofen (Rimadyl-V) in 209 clinical cases of canine degenerative joint disease. Vet Comp Orthop Trauma 5:140-144, 1992.
2. Knapp DW, Richardson RC, Chan TCK, et al: Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 8:273-278, 1994.
3. Vasseur PB, Johnson AL, Budsberg SC, et al: Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. JAVMA 206:807-811, 1995.
4. Budsberg SC, Johnston SA, Schwarz PD, et al: Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. JAVMA 214:206-210, 1999.
5. Kore AM: Toxicology of nonsteroidal antiinflammatory drugs. Vet Clin North Am Small Anim Pract 20:419-430, 1990.
6. Stanton ME, Bright RM: Gastroduodenal ulceration in dogs: Retrospective study of 43 cases and literature review. J Vet Intern Med 3:238-244, 1989.
7. Wallace MS, Zawie MS, Garvey MS: Gastric ulceration in the dog secondary to the use of nonsteroidal antiinflammatory drugs. JAAHA 26:467-472, 1990.
8. Vonderhaar MA, Salisbury SK: Gastroduodenal ulceration associated with flunixin meglumine administration in three dogs. JAVMA 203:92-95, 1993.
9. MacPhail CM, Lappin MR, Meyer DJ, et al: Hepatocellular roxicosis associated with administration of carprofen in 21 dogs. JAVMA 212:1895-1901, 1998.
10. Tandy J, Thorpe E: A fatal syndrome in a dog following administration of phenylbutazone. Vet Rec 81:398-399, 1967.
11. Brown SA: Renal effects of nonsteroidal anti-inflammatory drugs, in Kirk RW (ed): Current Veterinary Therapy X. Philadelphia, WB Saunders Co, 1989, pp 1158-1161.
12. Elwood C, Boswood A, Simpson K, et al: Renal failure after flunixin meglumine administration [letter]. Vet Rec 130: 582-583, 1992.
13. Gilmour MA, Walshaw R: Naproxen-induced toxicosis in a dog. JAVMA 191:1431-1432, 1987.
14. Mathews KA, Doherty T, Dyson DH, et al: Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia. Can Vet J 31:766-771, 1990.
15. Rubin SI: Nonsteroidal antiinflammatory drugs, prostaglandins, and the kidney. JAVMA 188:1065-1068, 1986.
16. Spyridakis LK, Bacia JJ, Barsanti JA, et al: Ibuprofen toxicosis in a dog. JAVMA 188:918-919, 1986.
17. Vaden SL, Levine J, Breitschwerdt EB: A retrospective case-control of acute renal failure in 99 dogs. J Vet Intern Med 11:58-64, 1997.
18. Badr KF, Jacobson HR: Arachidonic acid metabolites and the kidney, in Brenner BM, Rector FC (eds): The Kidney. Philadelphia, WB Saunders Co, 1991, pp 584-619.
19. Boothe DM: Prostaglandins: Physiology and clinical implications. Compend Contin Educ Pract Vet 6(11):1010-1021, 1984.
20. Bennett WM, Henrich WL, Stoff JS: The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations. Am J Kidney Dis 28(Suppl 1):S56-S62, 1996.
21. Murray MD, Brater DC: Renal toxicity of the nonsteroidal anti-inflammatory drugs. Ann Rev Pharmacol Toxicol 32: 435-465, 1993.
22. Dunn MJ: Clinical effects of prostaglandins in renal disease. Hosp Pract 19:99-113, 1984.
23. Stillman MT, Schlesinger PA: Nonsteroidal anti-inflammatory drug nephrotoxicity. Arch Intern Med 150:268-270, 1990.
24. Raymond KH, Lifschitz MD: Effects of prostaglandins on renal salt and water excretion. Am J Med 80(Suppl 1A):22-33, 1986.
25. Dibona GF: Prostaglandins and nonsteroidal anti-inflammatory drugs: Effects on renal hemodynamics. Am J Med 80(Suppl 1A):12-21, 1986.
26. Venturini CM, Isakson P, Needleman P: Non-steroidal antiinflammatory drug-induced renal failure: A brief review of the role of cyclo-oxygenase isoforms. Curr Opin Nephrol Hypertens 7:79-82, 1998.
27. Clive DM, Stoff JS: Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 310:563-572, 1984.
28. Patrono C, Dunn MJ: The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 32:1-12, 1987.
29. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232-235, 1971.
30. Xie W, Robertson DL, Simmons DL: Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Dev Res 25:249-265, 1992.
31. Pairet M, Churchill L, Trummlitz G, et al: Differential inhibition of cyclooxygenase-1 (COX-1) and -2 (COX-2) by NSAIDs: Consequences on anti-inflammatory activity versus gastric and renal safety. Inflammopharmacology 4:61-70, 1996.
32. Frolich JC, Stichtenoth DO: NSAID: Can renal side effects be avoided?, in Vane J, Botting J, Botting R (eds): Improved Non-Steroid Anti-Inflammatory Drugs COX-2 Enzyme Inhibitors. Dordrecht, The Netherlands, Kluwer Academic Publishers and William Harvey Press, 1996, pp 203-228.
33. Glaser K, Sung ML, O'Neill K, et al: Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 281:107-111, 1995.
34. Behrend EN, Grauer GF, Mani I, et al: Hospital-acquired acute renal failure in dogs: 29 cases (1983-1992). JAVMA 208:537-541, 1996.
35. Grauer GF: Fluid therapy in acute and chronic renal failure. Vet Clin North Am Small Anim Pract 28:609-622, 1998.
36. Paller MS, Manivel JC: Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney Int 42:1345-1354, 1992.
37. Toto RD: The role of prostaglandins in NSAID induced renal dysfunction. J Rheumatol 18(Suppl 28):22-25, 1991.
38. 1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs. JAVMA 202:251-256, 1993.
39. Johnston SA, Leib MS, Forrester SD, et al: The effect of misoprostol on aspirin-induced gastroduodenal lesions in dogs. J Vet Intern Med 9:32-38, 1995.
40. Davies C, Forrester SD, Troy GC, et al: Effects of a prostaglandin E, analogue, misoprostol, on renal function in dogs receiving nephrotoxic doses of gentamicin. Am J Vet Res 59:1048-1054, 1998.